Effectiveness of magnesium isoglycyrrhizinate on perioperative hepatic function protection in patients undergoing hepatectomy

Table 3 Analysis of prevalence of hepatic injury post hepatectomy using generalized estimating equation

	Estimates (SE)	Lower limit, upper limit	Z value	P value	OR (95%CI)
Perioperative vs postoperative treatment
POD 1	-0.34 (0.32)	-0.97, 0.29	-1.05	0.294	0.71 (0.38-1.34)
POD 3	-0.75 (0.26)	-1.25, -0.24	-2.88	0.004	0.47 (0.29-0.79)
POD 7	-0.60 (0.28)	-1.14, -0.06	-2.18	0.030	0.55 (0.32-0.94)
Discharge from hospital	0.14 (0.36)	-0.58, 0.85	0.38	0.705	1.15 (0.56-2.34)
Postoperative treatment
POD 3 vs POD 1	-0.77 (0.26)	-1.29, -0.25	-2.92	0.004	0.46 (0.28-0.78)
POD 7 vs POD 1	-3.00 (0.34)	-3.67, -2.35	-8.96	< 0.001	0.05 (0.03-0.10)
Discharge vs POD 1	-4.08 (0.40)	-4.86, -3.29	-10.20	< 0.001	0.02 (0.01-0.04)
Perioperative treatment
POD 3 vs POD 1	-1.18 (0.14)	-1.46, -0.91	-8.41	< 0.001	0.31 (0.23-0.40)
POD 7 vs POD 1	-3.27 (0.20)	-3.66, -2.88	-16.47	< 0.001	0.04 (0.03-0.06)
Discharge vs POD 1	-3.60 (0.21)	-4.01, -3.19	-17.17	< 0.001	0.03 (0.02-0.04)

POD: Postoperative day; CI: Confidence interval; OR: Odds ratio.